A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

NCT04679038 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: SHR-1701
DRUG: Famitinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.